Clinical Research Directory
Browse clinical research sites, groups, and studies.
Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardiac Surgery
Sponsor: Kartal Kosuyolu High Speciality Training and Research Hospital
Summary
This single-centre, prospective, randomised controlled trial examines whether a preoperative ultrasound-guided serratus posterior superior intercostal plane block (SPSIPB) reduces postoperative pain and opioid consumption in adults undergoing elective minimally invasive cardiac surgery through a right or left minithoracotomy. Patients are randomly allocated in a 1:1 ratio to SPSIPB with 30 mL of 0.25% bupivacaine or to no block. Both groups receive the same postoperative analgesia: intravenous paracetamol 1 g every 8 h and intravenous tramadol patient-controlled analgesia. The primary outcome is the resting pain score on the numeric rating scale (NRS) 1 hour after extubation.
Official title: Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia in Minimally Invasive Cardiac Surgery Via Thoracotomy: A Randomised Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
34
Start Date
2026-02-20
Completion Date
2026-09-01
Last Updated
2026-10-08
Healthy Volunteers
No
Interventions
Serratus Posterior Superior Intercostal Plane Block
Procedure: Serratus posterior superior intercostal plane block With the patient in the lateral decubitus position (operative side up), an 80-mm, 22-G block needle is advanced in-plane in a caudocranial direction under ultrasound guidance until its tip lies between the serratus posterior superior muscle and the third rib; after hydrodissection with 1-2 mL of saline, 30 mL of 0.25% bupivacaine is injected. The block is performed approximately 30 min before transfer to the operating room. Other name: SPSIPB Arm: SPSIPB group .
Locations (1)
Kosuyolu High Specialization Training and Research Hospital
Istanbul, Turkey (Türkiye)